Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Asset disposition Director comp.
|
LEXICON PHARMACEUTICALS, INC. (LXRX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2022 |
SC 13D/A
| Invus, L.P. reports a 47.6% stake in Lexicon Pharmaceuticals, Inc. |
08/01/2022 |
SC 13D/A
| Invus, L.P. reports a 47.6% stake in Lexicon Pharmaceuticals, Inc. |
01/21/2021 |
SC 13D/A
| Invus, L.P. reports a 50.3% stake in Lexicon Pharmaceuticals, Inc. |
01/05/2021 |
SC 13D/A
| Invus, L.P. reports a 50.3% stake in Lexicon Pharmaceuticals, Inc. |
12/16/2020 |
SC 13D/A
| Invus, L.P. reports a 50.3% stake in Lexicon Pharmaceuticals, Inc. |
06/29/2018 |
SC 13D/A
| Invus, L.P. reports a 56.9% stake in Lexicon Pharmaceuticals, Inc. |
06/04/2018 |
SC 13D/A
| Invus, L.P. reports a 55.8% stake in Lexicon Pharmaceuticals, Inc. |
04/10/2012 |
SC 13D/A
| Invus, L.P. reports a 52.1% stake in Lexicon Pharmaceuticals, Inc. |
02/24/2012 |
SC 13D/A
| Invus, L.P. has filed a Schedule 13D for Lexicon Pharmaceuticals, Inc. |
12/27/2011 |
SC 13D/A
| LEXICON PHARMACEUTICALS, INC. reports a 58.3% stake in Lexicon Pharmaceuticals, Inc. |
11/14/2011 |
SC 13D/A
| Invus, L.P. has filed a Schedule 13D for Lexicon Pharmaceuticals, Inc. |
03/19/2010 |
SC 13D/A
| Invus, L.P. reports a 48.9% stake in Lexicon Pharmaceuticals, Inc. |
10/15/2009 |
SC 13D/A
| LEXICON PHARMACEUTICALS, INC. reports a 40.3% stake in Lexicon Pharmaceuticals, Inc. |
10/08/2009 |
SC 13D/A
| LEXICON PHARMACEUTICALS, INC. reports a 40.3% stake in Lexicon Pharmaceuticals, Inc. |
|
|